Provenge

Bracing For Dendreon Q1 2013 Earnings - All Eyes On Provenge

Bracing For Dendreon Q1 2013 Earnings - All Eyes On Provenge

Seeking Alpha

Understanding Why Cancer Vaccines Fail

Understanding Why Cancer Vaccines Fail

Motley Fool

Will Dendreon Continue to Plummet?

Will Dendreon Continue to Plummet?

Wall St. Cheat Sheet

Is This Cancer Drug Really a Vaccine?

Is This Cancer Drug Really a Vaccine?

Motley Fool

Dendreon Jump-Starts Its New Direct-To-Consumer Ad Campaign

Dendreon Jump-Starts Its New Direct-To-Consumer Ad Campaign

Seeking Alpha

Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Motley Fool

Will Cost Cutting Offset Competitive Pressures For This Biotech In 2013?

Will Cost Cutting Offset Competitive Pressures For This Biotech In 2013?

Motley Fool

Dendreon Just Raised the Bar

Dendreon Just Raised the Bar

Motley Fool

[video]Dendreon: 3 Areas You Must Watch

[video]Dendreon: 3 Areas You Must Watch

Motley Fool

Dendreon Rises on Optimism Over Cancer Drug Provenge

Dendreon Rises on Optimism Over Cancer Drug Provenge

Bloomberg